» Articles » PMID: 19002835

FGF-2 Increases Osteogenic and Chondrogenic Differentiation Potentials of Human Mesenchymal Stem Cells by Inactivation of TGF-beta Signaling

Overview
Journal Cytotechnology
Specialties Biotechnology
Genetics
Date 2008 Nov 13
PMID 19002835
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Human mesenchymal stem cells (hMSCs) are able to self-replicate and differentiate into a variety of cell types including osteoblasts, chondrocytes, adipocytes, endothelial cells, and muscle cells. It was reported that fibroblast growth factor-2 (FGF-2) increased the growth rate and multidifferentiation potentials of hMSCs. In this study, we investigated the genes involved in the promotion of osteogenic and chondrogenic differentiation potentials of hMSCs in the presence of FGF-2. hMSCs were maintained in the medium with FGF-2. hMSCs were harvested for the study of osteogenic or chondrogenic differentiation potential after 15 days' culture. To investigate osteogenic differentiation, the protein levels of alkaline phosphatase (ALP) and the mRNA expression levels of osteocalcin were measured after the induction of osteogenic differentiation. Moreover, the investigation for chondrogenic differentiation was performed by measuring the mRNA expression levels of type II and type X collagens after the induction of chondrogenic differentiation. The expression levels of ALP, type II collagen, and type X collagen of hMSCs cultured with FGF-2 were significantly higher than control. These results suggested that FGF-2 increased osteogenic and chondrogenic differentiation potentials of hMSCs. Furthermore, microarray analysis was performed after 15 days' culture in the medium with FGF-2. We found that the overall insulin-like growth factor-I (IGF-I) and transforming growth factor-beta (TGF-beta) signaling pathways were inactivated by FGF-2. These results suggested that the inactivation of IGF-I and TGF-beta signaling promotes osteogenic and chondrogenic differentiation potential of hMSCs in the presence of FGF-2.

Citing Articles

Impact of Different Cell Types on the Osteogenic Differentiation Process of Mesenchymal Stem Cells.

Wang Z, Ren L, Li Z, Qiu Q, Wang H, Huang X Stem Cells Int. 2025; 2025:5551222.

PMID: 39980864 PMC: 11842143. DOI: 10.1155/sci/5551222.


Enhancing osteogenic differentiation in adipose-derived mesenchymal stem cells with Near Infra-Red and Green Photobiomodulation.

Da Silva D, Crous A, Abrahamse H Regen Ther. 2023; 24:602-616.

PMID: 38034860 PMC: 10682681. DOI: 10.1016/j.reth.2023.11.003.


Awakening of Dormant Breast Cancer Cells in the Bone Marrow.

Wieder R Cancers (Basel). 2023; 15(11).

PMID: 37296983 PMC: 10252003. DOI: 10.3390/cancers15113021.


Stromal Co-Cultivation for Modeling Breast Cancer Dormancy in the Bone Marrow.

Wieder R Cancers (Basel). 2022; 14(14).

PMID: 35884405 PMC: 9320268. DOI: 10.3390/cancers14143344.


Bioengineering Approaches for Delivering Growth Factors: A Focus on Bone and Cartilage Regeneration.

Shakoor S, Kibble E, El-Jawhari J Bioengineering (Basel). 2022; 9(5).

PMID: 35621501 PMC: 9137461. DOI: 10.3390/bioengineering9050223.


References
1.
Walsh S, Jefferiss C, Stewart K, Beresford J . TGFbeta1 limits the expansion of the osteoprogenitor fraction in cultures of human bone marrow stromal cells. Cell Tissue Res. 2003; 311(2):187-98. DOI: 10.1007/s00441-002-0679-8. View

2.
Solchaga L, Penick K, Porter J, Goldberg V, Caplan A, Welter J . FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol. 2004; 203(2):398-409. DOI: 10.1002/jcp.20238. View

3.
Quarto N, Longaker M . FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng. 2006; 12(6):1405-18. DOI: 10.1089/ten.2006.12.1405. View

4.
Sawada R, Ito T, Tsuchiya T . Changes in expression of genes related to cell proliferation in human mesenchymal stem cells during in vitro culture in comparison with cancer cells. J Artif Organs. 2006; 9(3):179-84. DOI: 10.1007/s10047-006-0338-z. View

5.
Ito T, Sawada R, Fujiwara Y, Seyama Y, Tsuchiya T . FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-beta2. Biochem Biophys Res Commun. 2007; 359(1):108-14. DOI: 10.1016/j.bbrc.2007.05.067. View